Comparable outcomes between Besifovir and other antiviral therapies in hepatocellular carcinoma development among patients with chronic hepatitis B

被引：0

作者：

Lee, Jae Seung ^{[1
]}

Lee, Won ^{[2
]}

Kim, Sang Gyune ^{[3
]}

Seo, Yeon Seok ^{[4
]}

Yu, Su Jong ^{[5
,6
]}

Yim, Hyung Joon ^{[7
]}

Lee, Hye Won ^{[1
]}

Kim, Mi Na ^{[1
]}

Kim, Beom Kyung ^{[1
]}

Park, Jun Yong ^{[1
]}

Kim, Do Young ^{[1
]}

Ahn, Sang Hoon ^{[1
]}

Kim, Seung Up ^{[1
]}

机构：

[1] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[2] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Internal Med, Sch Med, Bucheon, South Korea

[3] Soonchunhyang Univ, Coll Med, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea

[4] Korea Univ, Coll Med, Dept Internal Med, Anam Hosp, Seoul, South Korea

[5] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea

[7] Korea Univ, Coll Med, Div Gastroenterol & Hepatol, Dept Internal Med,Ansan Hosp, Ansan, South Korea

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-404

引用

页码：S799 / S799

页数：1

共 50 条

[31] Length of antiviral therapy and cirrhosis are key factors in the development of hepatocellular carcinoma among US veterans with chronic hepatitis B
Choi, Gina
Serper, Marina
Kaplan, David E.
Forde, Kimberly A.
HEPATOLOGY, 2015, 62 : 271A - 271A
[32] Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
Guo, Jiang
Gao, Xue-Song
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (14) : 3238 - 3251
[33] Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
Lee, Hye Won
Ahn, Sang Hoon
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8314 - 8321
[34] Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
Hye Won Lee
Sang Hoon Ahn
World Journal of Gastroenterology, 2016, (37) : 8314 - 8321
[35] Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
Jiang Guo
Xue-Song Gao
World Journal of Clinical Cases, 2021, 9 (14) : 3238 - 3251
[36] Development of prediction model for hepatocellular carcinoma in chronic hepatitis B patients
Ungtrakul, T.
Soonklang, K.
Dechma, J.
Kusuman, P.
Pongpun, W.
ANNALS OF ONCOLOGY, 2019, 30
[37] Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
Gordon, Stuart C.
Lamerato, Lois E.
Rupp, Loralee B.
Li, Jia
Holmberg, Scott D.
Moorman, Anne C.
Spradling, Philip R.
Teshale, Eyasu H.
Vijayadeva, Vinutha
Boscarino, Joseph A.
Henkle, Emily M.
Oja-Tebbe, Nancy
Lu, Mei
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 885 - 893
[38] Reduction of Cirrhosis and Hepatocellular Carcinoma With Antiviral Therapy in Chronic Hepatitis B
Liaw, Yun-Fan
HEPATOLOGY, 2013, 58 (05) : 1856 - 1856
[39] Risk of Hepatocellular Carcinoma Among Treated Patients With Chronic Hepatitis B vs Chronic Hepatitis C
Kim, Gi-Ae
Han, Seungbong
An, Jihyun
Lim, Young-Suk
HEPATOLOGY, 2014, 60 : 1092A - 1092A
[40] Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma
Bläckberg, J
Kidd-Ljunggren, K
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (01) : 18 - 23

← 1 2 3 4 5 →